Acorah Software Products - Accounts Production 16.1.300 false true false true No description of principal activity 24 April 2023 30 June 2024 30 June 2024 SC767083 Mr Razwan Shafi Mrs Shazma Shafi iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure SC767083 2023-04-23 SC767083 2024-06-30 SC767083 2023-04-24 2024-06-30 SC767083 frs-core:CurrentFinancialInstruments 2024-06-30 SC767083 frs-bus:PrivateLimitedCompanyLtd 2023-04-24 2024-06-30 SC767083 frs-bus:FilletedAccounts 2023-04-24 2024-06-30 SC767083 frs-bus:Micro-entities 2023-04-24 2024-06-30 SC767083 frs-bus:AuditExempt-NoAccountantsReport 2023-04-24 2024-06-30 SC767083 frs-bus:Director1 2023-04-24 2024-06-30 SC767083 frs-bus:Director2 2023-04-24 2024-06-30
Registered number: SC767083
Rss Pharma Ltd
Financial Statements
For the Period 24 April 2023 to 30 June 2024
Khokhar McAdam Ltd
Chartered Accountants
1 Eagle Street
Glasgow
G4 9XA
Balance Sheet
Registered number: SC767083
30 June 2024
£
Fixed assets 784,787
Current assets 272,446
Creditors: Amounts Falling Due Within One Year (991,725 )
NET CURRENT LIABILITIES (719,279 )
TOTAL ASSETS LESS CURRENT LIABILITIES 65,508
NET ASSETS 65,508
CAPITAL AND RESERVES 65,508

Notes

1. General Information
Rss Pharma Ltd is a private company, limited by shares, incorporated in Scotland, registered number SC767083 . The registered office is 42 Broompark Drive, Glasgow, G77 5DZ.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 9
9
Page 0
Page 1
For the period ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Razwan Shafi
Director
25 February 2025